RBC Capital Reiterates Outperform on Surgery Partners, Maintains $19 Price Target

Benzinga · 3d ago
RBC Capital analyst Ben Hendrix reiterates Surgery Partners (NASDAQ:SGRY) with a Outperform and maintains $19 price target.